Statistics for Biodesix (id:6788 BDSX)

Valuation metrics

Market cap

183.29M

Enterprise value

227.23M

Trailing P/E (ttm)

-2.04

Forward P/E

-5.73

PEG ratio

-5.73

Price/Sales (ttm)

2.80

Price/Book (mrq)

6.56

Enterprise Value/Revenue

3.47

Enterprise Value/EBITDA

-7.77

Overview

Shares outstanding

145.47M

Float

68.31M

Shares short

415.74K

% Held by insiders

0.47%

% Held by institutions

0.39%

Average volume (10 days)

618.31K

Average volume (90 days)

Price summary

52-Week low

1.11

52-Week high

2.21

52-Week change

-13.18%

Beta

1.21

50-Day moving average

1.62

200-Day moving average

1.57

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-66.84%

Operating margin

-47.33%

Operational effectiveness

Return on assets

-22.79%

Return on equity

-331.82%

Income statement

Revenue (ttm)

0.57

Revenue per share (ttm)

0.57

Quarterly revenue growth (yoy)

Gross profit (ttm)

36.08M

EBITDA

-29,259,000.00

Net income to common (ttm)

-43,819,000.00

Diluted EPS (ttm)

-0.37

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

31.41M

Total cash per share (mrq)

0.22

Total debt (mrq)

62.98M

Total Debt/Equity (mrq)

226.08

Current ratio (mrq)

339.60%

Book value per share (mrq)

0.19

Cash flow

Cash flow statement

-56,836,000.00

Levered free cash flow (LFCF)

-43,438,876.00